You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Suppliers and packagers for DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
B Braun DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631 NDA B. Braun Medical Inc. 0264-7608-00 12 CONTAINER in 1 CASE (0264-7608-00) / 1000 mL in 1 CONTAINER 1988-02-24
B Braun DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631 NDA B. Braun Medical Inc. 0264-7608-10 24 CONTAINER in 1 CASE (0264-7608-10) / 500 mL in 1 CONTAINER 1988-02-24
B Braun DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631 NDA B. Braun Medical Inc. 0264-7610-00 12 CONTAINER in 1 CASE (0264-7610-00) / 1000 mL in 1 CONTAINER 1988-02-24
B Braun DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER dextrose; sodium chloride INJECTABLE;INJECTION 019631 NDA B. Braun Medical Inc. 0264-7610-10 24 CONTAINER in 1 CASE (0264-7610-10) / 500 mL in 1 CONTAINER 1988-02-24
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Dextrose 10% and Sodium Chloride 0.9% in Plastic Containers

Last updated: August 4, 2025

Introduction

The procurement of pharmaceutical-grade dextrose 10% and sodium chloride 0.9% in plastic containers is critical for hospitals, clinics, and pharmaceutical companies. These solutions are staple intravenous (IV) fluids used for hydration, electrolyte balance, and medical therapies. Ensuring a reliable supply chain from reputable manufacturers guarantees safety, compliance, and consistent quality. This article provides an in-depth overview of key suppliers, their market positions, quality standards, and strategic considerations for procurement professionals.

Global Market Landscape for Pharmaceutical Dextrose and Sodium Chloride Solutions

The global market for IV solutions is dynamic, driven by increasing healthcare needs, expanding hospital infrastructure, and regulatory standards demanding high-quality manufacturing. Major suppliers operate under stringent Good Manufacturing Practices (GMP), ensuring compliance with agencies such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory authorities.

Major Suppliers for Dextrose 10% in Plastic Containers

Dextrose 10% in water is widely produced, with several key players dominating the global market:

  • Fresenius Kabi: A leading German healthcare company, Fresenius Kabi offers a broad portfolio of IV fluids, including dextrose solutions. Known for rigorous quality standards and extensive distribution networks, they serve hospitals worldwide.

  • Baxter International: Specializing in infusion therapies, Baxter is a major supplier of dextrose and other IV solutions in standardized containers. Their products meet global regulatory standards, with widespread availability.

  • B. Braun Melsungen AG: A German medical device and pharmaceutical company, B. Braun supplies a comprehensive range of IV fluids, emphasizing high purity, safety, and container integrity.

  • Pfizer: As a pharmaceutical giant, Pfizer manufactures and supplies IV solutions, including dextrose 10%, especially tailored for institutional use.

  • Huadong Medicine (China): An increasingly significant regional supplier, Huadong offers competitively priced dextrose solutions compatible with international standards.

Major Suppliers for Sodium Chloride 0.9% in Plastic Containers

Sodium chloride 0.9% (normal saline) solutions are globally essential. Leading suppliers include:

  • Fresenius Kabi: Also a prominent producer of sodium chloride solutions, they prioritize high sterility standards and container integrity.

  • Baxter International: Known for their sterile, pyrogen-free saline, Baxter supplies in varying container formats, including plastics.

  • B. Braun Melsungen AG: Offers sodium chloride solutions with rigorous quality control, meeting ISO and pharmacopeial requirements.

  • Pfizer: Provides sodium chloride 0.9% solutions, ensuring compliance with various international regulations.

  • Otsuka Pharmaceutical: A Japanese company with growing global presence, Otsuka supplies standardized saline solutions for diverse clinical settings.

Criteria for Selecting Suppliers

Choosing reliable suppliers for dextrose 10% and sodium chloride 0.9% in plastic containers involves assessing:

  • Regulatory Compliance: Certificates of GMP, ISO standards, and approvals from FDA or EMA.

  • Product Quality and Safety: Sterility, particulate matter limits, pyrogen testing, and container integrity.

  • Manufacturing Capacity and Supply Continuity: Ability to meet demand volumes, disaster recovery plans, and lead times.

  • Pricing and Contract Flexibility: Competitive pricing models, volume discounts, and contractual terms.

  • Distribution Network: Global reach and logistics capabilities, ensuring timely delivery.

  • Track Record and Reputation: Past audit outcomes, customer testimonials, and reputation for consistent quality.

Regional and Niche Suppliers

In addition to global giants, regional suppliers may offer competitive alternatives, particularly in emerging markets. Regional companies often comply with local regulatory standards while maintaining international certifications. For example:

  • Sino Pharm and Shanghai Pharma in China
  • Indo-American Pharma in India
  • Nippon Kayaku in Japan

Selecting regional suppliers can facilitate cost savings and supply chain resilience but warrants thorough quality audits.

Emerging Trends and Supply Chain Considerations

The pharmaceutical consumables market is evolving with advances in container technology (e.g., polypropylene vs. polyethylene), single-use systems, and standardized labeling. Also, increasing regulation around single-use plastics and environmental sustainability impact supplier selection.

For procurement, it's crucial to:

  • Verify expiration dating and traceability.
  • Conduct periodic audits of supplier manufacturing sites.
  • Monitor regulatory updates influencing import/export licenses.
  • Establish strategic stockpiles to counter supply disruptions.

Key Suppliers Summary Table

Supplier Geographic Focus Product Range Regulatory Certifications Notable Strengths
Fresenius Kabi Global Extensive IV solutions including dextrose & saline GMP, ISO, USFDA, EMA certified Wide distribution, high quality standards
Baxter International Global Wide array of IV fluids GMP, ISO, USFDA, EMA certified Reliable supply chain
B. Braun Melsungen AG Europe, Global IV solutions, infusion systems GMP, ISO, USFDA, EMA certified High container integrity
Pfizer Global Pharmaceutical-grade IV solutions GMP, ISO, USFDA, EMA certified Extensive R&D and manufacturing capacity
Huadong Medicine China, Asia-Pacific Cost-effective IV solutions Chinese GMP, ISO standards Competitive pricing, local market focus

Conclusion

Reliability in sourcing dextrose 10% and sodium chloride 0.9% in plastic containers hinges on evaluating quality standards, regulatory compliance, manufacturing capacity, and logistical excellence. Leading global suppliers like Fresenius Kabi, Baxter, and B. Braun dominate the market, offering proven quality and extensive distribution networks. Regional suppliers provide competitive alternatives, especially in emerging markets. Strategic procurement decisions should integrate supplier reputation, regulatory adherence, and supply chain resilience to ensure uninterrupted access to these essential IV solutions.


Key Takeaways

  • Global Leaders Dominate: Major suppliers such as Fresenius Kabi and Baxter are preferred for their reliable quality and regulatory compliance.

  • Regulatory & Quality Standards Are Paramount: Ensure suppliers hold GMP, ISO, and relevant certifiable standards aligned with market regulations.

  • Regional Suppliers Can Offer Cost-Effective Alternatives: Especially relevant in emerging markets but necessitate thorough quality audits.

  • Supply Chain Resilience Is Critical: Diversify suppliers and consider local/regional sources to mitigate disruptions.

  • Market Trends Affect Procurement: Evolving container technologies and sustainability concerns influence supplier offerings and selection.


Frequently Asked Questions (FAQs)

  1. What are the primary regulatory standards to verify when selecting suppliers for IV solutions?
    Verify GMP certification, ISO standards, and approvals from relevant authorities such as the FDA (USA) and EMA (Europe). These ensure manufacturing processes adhere to global safety and quality benchmarks.

  2. How can I assess the quality of dextrose and saline solutions from regional suppliers?
    Conduct supplier audits, review quality control documentation, and request batch testing results for sterility, particulate matter, and pyrogen levels. Certifications and past audit reports are also critical indicators.

  3. Are there environmental considerations linked to plastic containers used for IV solutions?
    Yes. Increased regulatory and public scrutiny surround single-use plastics. Suppliers investing in recyclable or environmentally friendly packaging may offer long-term advantages.

  4. What logistical factors should be considered in supplier selection?
    Consider delivery lead times, regional distribution capabilities, customs clearance, and contingency planning for supply disruptions. Having multiple suppliers mitigates risks.

  5. Can I source dextrose 10% and saline solutions from regional or local manufacturers?
    Yes, especially in emerging markets. Ensure these vendors meet international quality standards, possess necessary certifications, and have a reliable supply history.


Sources:

  1. [1] Pharmaceutical guidelines and manufacturing practices. World Health Organization (WHO).
  2. [2] Market analysis on IV solution suppliers. IBISWorld Industry Reports.
  3. [3] Company official websites and certification disclosures for Fresenius Kabi, Baxter, and B. Braun.
  4. [4] Regulatory standards documentation. US Food and Drug Administration (FDA) and European Medicines Agency (EMA).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.